novel 3d ex vivo paltform were discussed at the nilogen immuno-oncology 2018 summit

A Novel 3D Ex Vivo Platform of Fresh Patient Tumor Tissue for Immuno-Oncology Drug Development

Soner Altiok, M.D., Ph.D., Chief Scientific Officer, Nilogen Oncosystems. Cambridge Healthtech Institute’s 6 th Annual Immuno-oncology Summit. 08/27/2018 to 08/31/18. Boston, MA, USA.

DOWNLOAD presentation